The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

Thu, 27th Feb 2020 17:56

(Alliance News) - The following is a round-up of company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Burford Capital Ltd - The litigation finance firm adds Christopher Bogart, chief executive officer and a company founder, to the board, as proposed back in January. Also hires Robert Gillespie, most recently director general of the UK Takeover Panel, and John Sievwright, former chief operating officer for International at Merrill Lynch, as independent non-executive directors. Peter Middleton to step down as chair at 2021 annual general meeting, succeeded by Deputy Chair Steve Wilson. Burford said it will continue to refresh its board and expects to add a further independent director prior to the 2021 AGM. The company is seeking a US listing, and it said Thursday that if successful, it will look to add another US director. Burford was the target of a short-selling attack back in August of last year by Muddy Waters Capital LLC, which charged that Burford "is a poor business masquerading as a great one".

----------

OnTheMarket PLC - Property portal hires Rupert Sebag-Montefiore as independent non-executive director. Sebag-Montefiore served as chief executive officer of estate agent Savills PLC's principal UK subsidiary, as well as head of Global Residential.

----------

Laura Ashley Holdings PLC - Chief Executive Officer Kwan Cheong Ng steps down Thursday to become non-executive director. Had been expected to remain an executive director until end of April. Chief Operating Officer Katharine Poulter promoted to CEO.

----------

ConvaTec Group PLC - Hires Brian May as non-executive director from March 2. May was chief financial officer of Bunzl PLC from 2016 to 2019.

----------

RSA Insurance Group PLC - Alastair Barbour plans to step down as non-executive director in early October, having served nine years on the insurer's board. Clare Bousfield joins board on April 1 and will succeed Barbour as chair of audit committee in October.

----------

AFC Energy PLC - Company Secretary Graeme Lewis to become finance director as well.

----------

REACT Group PLC - Appoints Shaun Doak, managing director of REACT Specialist Cleaning Ltd, to board. Gill Leates moves from executive to non-executive chair. Both changes immediate.

----------

Open Orphan PLC - Chief Financial Officer Leo Toole added to board. Toole was interim CFO and then confirm as permanent earlier this month. He is a 20-year pharmaceuticals and medical technology veteran, having held senior finance positions at the US's Procter & Gamble Co and other multinationals.

----------

Frenkel Topping Group PLC - Elaine Cullen-Grant promoted from financial controller to the board as chief financial officer. Cullen-Grant succeeds Stephen Bentley, who retires on March 1.

----------

Dialight PLC - Karen Oliver and Gotthard Haug hired as non-executive directors from April 1. Oliver is former managing director of Johnson Matthey PLC's Chemicals business. Haug is executive chair of electronics repair and service provider Ivy Technology. Steve Good to step down as director from March 31.

----------

Baronsmead Second Venture Trust PLC - Tim Farazmand hired as independent non-executive director from May 1. Was chair of the British Venture Capital Association.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Dec 2020 11:38

Open Orphan upbeat on progress with nasal Covid-19 vaccine

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Monday that the first in-human study of the Codagenix intranasal SARS-CoV-2 vaccine candidate for Covid-19 had gained approval from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

Read more
24 Nov 2020 16:27

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

Read more
19 Nov 2020 21:18

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

Read more
5 Nov 2020 16:32

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

Read more
30 Oct 2020 11:30

Open Orphan secures new two-year contract with German client

(Sharecast News) - Pharmaceutical services company Open Orphan announced a new two-year contract with an unnamed tier 1 Germany-based pharmaceutical company on Friday.

Read more
30 Oct 2020 11:07

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Read more
20 Oct 2020 15:59

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

Read more
20 Oct 2020 09:49

Open Orphan to assist UK govt in Covid-19 study

(Sharecast News) - Pharmaceutical services company Open Orphan has signed a contract with the UK Government that will see the firm assist in the development of a Covid-19 human challenge study model to safely speed up the development of an efficacious vaccine.

Read more
16 Oct 2020 15:24

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

Read more
16 Oct 2020 08:57

Open Orphan continues talks over coronavirus challenge study

(Sharecast News) - Open Orphan updated the market on its talks with the UK government and other partners for a coronavirus challenge study in the UK on Friday, confirming that "advanced negotiations" were ongoing.

Read more
30 Sep 2020 18:37

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

Read more
28 Sep 2020 19:34

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

Read more
24 Sep 2020 17:35

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

Read more
22 Sep 2020 19:35

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

Read more
22 Sep 2020 09:43

Open Orphan subsidiary wins 'important' new contract

(Sharecast News) - Pharmaceutical contract research organisation Open Orphan secured an "important" new contract to support an unnamed European client via its French subsidiary, Venn Life Sciences.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.